DCF — GILLETTE CHILDRENS SPECIALTY HEALTH
Enterprise Value: $-284.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-284.9M
Enterprise Value
$-93.4M
PV of Cash Flows
$-191.5M
PV of Terminal Value
$-308.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $274.7M | $-16.0M | -6.0% | $-27.6M | $-25.1M |
| Year 2 | $282.9M | $-13.6M | -5.0% | $-25.6M | $-21.2M |
| Year 3 | $291.4M | $-11.1M | -4.0% | $-23.5M | $-17.6M |
| Year 4 | $300.2M | $-10.0M | -3.0% | $-22.7M | $-15.5M |
| Year 5 | $309.2M | $-9.5M | -3.0% | $-22.6M | $-14.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-284.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$266.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06316482464305434
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5